IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,113,986 | +42.6% | 216,868 | +16.6% | 0.71% | +13.5% |
| Q1 2023 | $2,885,558 | +2.9% | 186,045 | +17.7% | 0.63% | -15.9% |
| Q4 2022 | $2,804,607 | -0.1% | 158,006 | +160.0% | 0.75% | +3.9% |
| Q4 2020 | $2,807,000 | -46.9% | 60,781 | -59.5% | 0.72% | -48.6% |
| Q3 2020 | $5,284,000 | +73.4% | 150,151 | +20.0% | 1.40% | +63.1% |
| Q2 2020 | $3,047,000 | +387.5% | 125,125 | +211.8% | 0.86% | +195.9% |
| Q1 2020 | $625,000 | – | 40,125 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |